TXA for Reducing Blood Loss in Hip Fractures
Effect of Early Administration of TXA in Adult Hip Fractures
Recruiting
Phase 2
Phase 3
Interventional Study
Postoperative Blood Loss
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 170 (estimated)
- Sponsor
- Ascension Health · Industry
Who this trial is looking for
This trial is looking for adults with hip fractures who need surgery. Participants will receive tranexamic acid (TXA) before and after their operation to help reduce blood loss.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years or older
- I have an acute hip fracture
- I am undergoing surgery for my hip fracture
You may not be able to join if
- I have multiple injuries (polytrauma)
- I have had a previous surgery on the same hip
- I have a bleeding disorder
- I had a blood clot or stroke within the last 6 months
- I have a history of seizures
- I am currently on birth control
- I am pregnant
- I have an active blood clot or stroke
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This is a prospective clinical study designed to assess blood loss in intracapsular and extracapsular hip fractures undergoing operative fixation at a Level II trauma center. It is well established in the orthopedic literature that tranexamic acid (TXA) decreases blood loss and need for postoperative blood transfusion in hip fracture patients as well as total joint arthroplasty patients. A typical…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 1\. All adult (18 years old or older) hip fracture patients presenting with an acute hip fracture and undergoing operative fixation
Exclusion Criteria:
1. Polytrauma patients
2. Previous operation on the ipsilateral hip
3. Patients with coagulopathies (Factor V Leiden, Sickl…
Contacts